Phosphodiesterase 4 cAMP phosphodiesterases as targets for novel anti-inflammatory therapeutics
Cyclic nucleotides are powerful signaling molecules and their sole means of removal is through the action of cyclic nucleotide phosphodiesterases (PDEs). Elevating levels of cAMP is beneficial in many diseases, including neurological conditions, cancers, viral infections and most inflammatory disord...
Main Author: | Simon J MacKenzie |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2004-01-01
|
Series: | Allergology International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1323893015311047 |
Similar Items
-
Protein Kinase A Regulates Platelet Phosphodiesterase 3A through an A-Kinase Anchoring Protein Dependent Manner
by: Jawad S. Khalil, et al.
Published: (2024-06-01) -
Impaired cAMP processivity by phosphodiesterase-protein kinase A complexes in acrodysostosis
by: Varun Venkatakrishnan, et al.
Published: (2023-09-01) -
Involvement of Src family of kinases and cAMP phosphodiesterase in the luteinizing hormone/chorionic gonadotropin receptor-mediated signaling in the corpus luteum of monkey
by: Kunal Shah B, et al.
Published: (2012-03-01) -
The Role of Cyclic AMP Signaling in Cardiac Fibrosis
by: Marion Delaunay, et al.
Published: (2019-12-01) -
Oral small-molecule tyrosine kinase 2 and phosphodiesterase 4 inhibitors in plaque psoriasis: a network meta-analysis
by: Yuanyuan Xu, et al.
Published: (2023-06-01)